Then, multivariate analysis using the two extracted factors revealed that both factors were associated with the occurrence of grade ≥ 3 neutropenia (history of ICI treatment: p = 0.018, prophylactic administration of G-CSF: p < 0.001). The gene discussed is CSF3; the disease is Decreased total neutrophil count.